[HTML][HTML] Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the …

S Uchiyama, S Goto, H Origasa, N Uemura, K Sugano… - Heart and Vessels, 2020 - Springer
Aspirin should be used for the prevention of cardiovascular (CV) events by the risk–benefit
balance. This study was conducted to clarify CV and bleeding events in Japanese aspirin …

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of …

S Uchiyama, S Goto, H Origasa… - Heart and …, 2020 - pubmed.ncbi.nlm.nih.gov
Aspirin should be used for the prevention of cardiovascular (CV) events by the risk-benefit
balance. This study was conducted to clarify CV and bleeding events in Japanese aspirin …

[HTML][HTML] Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the …

S Uchiyama, S Goto, H Origasa, N Uemura… - Heart and …, 2020 - ncbi.nlm.nih.gov
Aspirin should be used for the prevention of cardiovascular (CV) events by the risk–benefit
balance. This study was conducted to clarify CV and bleeding events in Japanese aspirin …

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of …

S Uchiyama, S Goto, H Origasa, N Uemura… - Heart and …, 2019 - europepmc.org
Aspirin should be used for the prevention of cardiovascular (CV) events by the risk–benefit
balance. This study was conducted to clarify CV and bleeding events in Japanese aspirin …

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of …

S Uchiyama, S Goto, H Origasa, N Uemura… - Heart & …, 2020 - search.ebscohost.com
Aspirin should be used for the prevention of cardiovascular (CV) events by the risk–benefit
balance. This study was conducted to clarify CV and bleeding events in Japanese aspirin …